Lenvatinib with pembrolizumab and transarterial chemoembolization for untreated localised hepatocellular carcinoma [ID5117]

  • In development
  • GID-TA11008
  • Expected publication date: TBC

29291-Lenvatinib-and-Pembrolizumab-with-TACE-for-Hepatocellular-Carcinoma-V1.0-FEB2022-NONCONF.pdf (nihr.ac.uk)